Eva Hellström‐Lindberg
- Hematology top 0.02%
- Acute Myeloid Leukemia Research 142
- Hematopoietic Stem Cell Transplantation 25
- Multiple Myeloma Research and Treatments 17
- Genetics top 0.1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 41
- Chronic Lymphocytic Leukemia Research 31
- Hemoglobinopathies and Related Disorders 26
- Emergency Medicine top 1%
- Molecular Biology top 1%
- Histone Deacetylase Inhibitors Research 14
-
- Lymphoma Diagnosis and Treatment 13
- Co-authors
- Anna PorwitDaniel A. ArberJames W. VardimanAyalew TefferiClara D. BloomfieldMichael J. BorowitzJüergen ThieleRichard D. Brunning
- Cited by
- HematologyGeneticsEmergency Medicine
- Partner nations
- SwedenUnited KingdomGermany
In The Last Decade
Eva Hellström‐Lindberg
176 papers receiving 10.4k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Hematology 8.2k
- Genetics 3.8k
- Emergency Medicine 599
- Molecular Biology 4.0k
- Public Health, Environmental and Occupational Health 1.4k
Countries citing papers authored by Eva Hellström‐Lindberg
This map shows the geographic impact of Eva Hellström‐Lindberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hellström‐Lindberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hellström‐Lindberg more than expected).
Fields of papers citing papers by Eva Hellström‐Lindberg
This network shows the impact of papers produced by Eva Hellström‐Lindberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hellström‐Lindberg. The network helps show where Eva Hellström‐Lindberg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eva Hellström‐Lindberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 78 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 8 | |
| 10 | 2020 | 36 | |
| 11 | 2020 | 31 | |
| 12 | 2019 | 53 | |
| 13 | 2019 | 14 | |
| 14 | 2017 | 61 | |
| 15 | VALIDATION OF PROGNOSTIC SCORING SYSTEMS FOR MYELODYSPLASTIC SYNDROMES IN THE SWEDISH MDS-REGISTER | 2016 | 1 |
| 16 | 2011 | 332 | |
| 17 | 2011 | 49 | |
| 18 | Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemiabreakdown → | 2009 | 698 |
| 19 | NEW INSIGHTS INTO THE BIOLOGY OF REFRACTORY ANEMIA WITH RING SIDEROBLASTS (RARS) AND IDENTIFICATION OF ERYTHROID G-CSF TARGETS BY GENE EXPRESSION PROFILING | 2009 | 1 |
| 20 | Cytogenetic risk group and cytogenetic response predict outcome of patients with poor-risk mds and secondary aml treated with intensive chemotherapy and stem cell transplantation in a joint study (CRIANT) of the EORTC, EBMT, SAKK, HOVON and GIMEMA leukemia groups | 2001 | 1 |
About Eva Hellström‐Lindberg
Eva Hellström‐Lindberg is a scholar working on Hematology, Genetics and Emergency Medicine, having authored 187 papers that have together received 10.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (142 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (41 papers), Chronic Lymphocytic Leukemia Research (31 papers), Hemoglobinopathies and Related Disorders (26 papers), Hematopoietic Stem Cell Transplantation (25 papers), Multiple Myeloma Research and Treatments (17 papers), Histone Deacetylase Inhibitors Research (14 papers) and Lymphoma Diagnosis and Treatment (13 papers). The work is most often cited by research in Hematology (8.2k citations), Genetics (3.8k citations) and Emergency Medicine (599 citations). Eva Hellström‐Lindberg has collaborated with scholars based in Sweden, United Kingdom and Germany. Frequent co-authors include Anna Porwit, Daniel A. Arber, James W. Vardiman, Ayalew Tefferi, Clara D. Bloomfield, Michael J. Borowitz, Jüergen Thiele, Richard D. Brunning, Nancy L. Harris and Michelle M. Le Beau. Their work appears in journals such as Blood, Leukemia Research, British Journal of Haematology, Leukemia and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.